{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:16:41Z","timestamp":1775697401712,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705101"],"award-info":[{"award-number":["2022YFC2705101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Science and Health Joint Medical Research Project","award":["2023GGXM001"],"award-info":[{"award-number":["2023GGXM001"]}]},{"name":"Program for Youth Innovation in Future Medicine, and Chongqing Medical University","award":["W0098"],"award-info":[{"award-number":["W0098"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Primary glomerular diseases (PGDs), including nephrotic syndrome (NS), membranous nephropathy (MN), and IgA nephropathy (IgAN), are complex renal conditions influenced by immune system dysregulation. Although associations between immune cell phenotypes and PGDs have been observed, the precise causal relationships have not been fully elucidated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Utilizing genetic association data from genome-wide association studies (GWASs), we investigated 731 immunophenotypes in relation to PGDs. A bidirectional two-sample Mendelian randomization (MR) approach, primarily employing inverse variance weighting (IVW), was conducted to establish causality. MR-Egger, weighted median, simple mode, and weighted mode were used as complementary methods to reinforce the robustness and validity of the results. Sensitivity analyses further validated the sensitivity and stability of our results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 38 immunophenotypes suggestively related to IgAN, with 20 as risk factors and 18 as protective effects. Six immunophenotypes remained significant after Bonferroni correction: The percentage of CD25hi among T cells; the percentage of CD25hi CD45RA\u2212 CD4 not T regulatory (Treg) among T cells; the percentage of CD25hi CD45RA\u2212 CD4 not Treg within the CD4+ T cell population; CX3CR1 expression on monocytes; CD40 expression on monocytes; and CD64 expression on CD14+ CD16\u2212 monocytes. In the validation analysis of IgAN, CD3 expression on effector memory CD4+ T cells further confirmed the predisposing risk role of effector memory T cells in the development of IgAN. Additionally, the MR analysis demonstrated suggestive associations between 25 immunophenotypes and MN (8 risk factors and 17 protective factors), as well as between 22 immunophenotypes and NS (10 risk factors and 12 protective factors). Last, by intersecting the immunophenotypes showing suggestive associations with PGDs, we identified two common immunophenotypes shared by IgAN and MN, three by IgAN and NS, and one by MN and NS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This genetic-level investigation uncovers causal associations between immunophenotypes and PGDs, providing valuable insights into the immunological underpinnings of PGDs. Our findings suggest potential targets for treatment strategies, thereby facilitating more personalized and effective therapeutic approaches in PGDs management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf057","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T02:06:19Z","timestamp":1740449179000},"source":"Crossref","is-referenced-by-count":2,"title":["Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study"],"prefix":"10.1093","volume":"18","author":[{"given":"Wenhao","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Nephrology Children's Hospital of Chongqing Medical University , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"National Clinical Research Center for Child Health and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Ministry of Education Key Laboratory of Child Development and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology Children's Hospital of Chongqing Medical University , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"National Clinical Research Center for Child Health and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Ministry of Education Key Laboratory of Child Development and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology Children's Hospital of Chongqing Medical University , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"National Clinical Research Center for Child Health and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Ministry of Education Key Laboratory of Child Development and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology Children's Hospital of Chongqing Medical University , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"National Clinical Research Center for Child Health and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Ministry of Education Key Laboratory of Child Development and Disorders , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]},{"name":"Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases , Chongqing , ; , Chongqing , ; , Chongqing , ; , Chongqing ,","place":["China China China China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"2025040309392680900_bib1","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJM199809243391306","article-title":"Glomerulonephritis","volume":"339","author":"Hricik","year":"1998","journal-title":"N Engl J Med"},{"key":"2025040309392680900_bib2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"key":"2025040309392680900_bib3","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2025040309392680900_bib4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-023-00476-9","article-title":"IgA nephropathy","volume":"9","author":"Stamellou","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"2025040309392680900_bib5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.kint.2024.08.012","article-title":"Targeting APRIL in the treatment of glomerular diseases","volume":"106","author":"Cheung","year":"2024","journal-title":"Kidney Int"},{"key":"2025040309392680900_bib6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jfma.2023.06.020","article-title":"Targeted therapy in glomerular diseases","volume":"123","author":"Lin","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"2025040309392680900_bib7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ckj\/sfad025","article-title":"Immune abnormalities in IgA nephropathy","volume":"16","author":"Gentile","year":"2023","journal-title":"Clin Kidney J"},{"key":"2025040309392680900_bib8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(23)01051-6","article-title":"Childhood nephrotic syndrome","volume":"402","author":"Vivarelli","year":"2023","journal-title":"Lancet"},{"key":"2025040309392680900_bib9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2025040309392680900_bib10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"2025040309392680900_bib11","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1681\/ASN.2020121760","article-title":"Mendelian randomization analysis as a tool to gain insights into causes of diseases: a primer","volume":"32","author":"Tin","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2025040309392680900_bib12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"2025040309392680900_bib13","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet"},{"key":"2025040309392680900_bib14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"2025040309392680900_bib15","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"key":"2025040309392680900_bib16","doi-asserted-by":"publisher","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"2025040309392680900_bib17","doi-asserted-by":"publisher","first-page":"1344773","DOI":"10.3389\/fimmu.2024.1344773","article-title":"Causality of genetically proxied immunophenotypes on cardiovascular diseases: a Mendelian randomization study","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"2025040309392680900_bib18","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2025040309392680900_bib19","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1111\/ene.15848","article-title":"Associations between gut microbiota and Parkinson disease: a bidirectional Mendelian randomization analysis","volume":"30","author":"Jiang","year":"2023","journal-title":"Euro J Neurology"},{"key":"2025040309392680900_bib20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2025040309392680900_bib21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2025040309392680900_bib22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025040309392680900_bib23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41588-018-0164-2","article-title":"Publisher correction: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"2025040309392680900_bib24","doi-asserted-by":"publisher","first-page":"2381593","DOI":"10.1080\/0886022X.2024.2381593","article-title":"Causal role of immune cells in IgA nephropathy: a Mendelian randomization study","volume":"46","author":"Shu","year":"2024","journal-title":"Ren Fail"},{"key":"2025040309392680900_bib25","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"2025040309392680900_bib26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clim.2018.01.003","article-title":"Human CD4(+) CD25(+) CD127(hi) cells and the Th1\/Th2 phenotype","volume":"188","author":"Narsale","year":"2018","journal-title":"Clin Immunol"},{"key":"2025040309392680900_bib27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/ijms21041389","article-title":"Immunological pattern in IgA nephropathy","volume":"21","author":"Esteve Cols","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025040309392680900_bib28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12788","article-title":"The TCR is an allosterically regulated macromolecular machinery changing its conformation while working","volume":"291","author":"Schamel","year":"2019","journal-title":"Immunol Rev"},{"key":"2025040309392680900_bib29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nri2887","article-title":"Mechanisms for T cell receptor triggering","volume":"11","author":"van der Merwe","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"2025040309392680900_bib30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"2025040309392680900_bib31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10157-018-1665-0","article-title":"T cells in IgA nephropathy: role in pathogenesis, clinical significance and potential therapeutic target","volume":"23","author":"Ruszkowski","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2025040309392680900_bib32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11255-016-1444-3","article-title":"MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy","volume":"49","author":"Yang","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"2025040309392680900_bib33","doi-asserted-by":"publisher","first-page":"e0112305","DOI":"10.1371\/journal.pone.0112305","article-title":"DNA methylation in Cosmc promoter region and aberrantly glycosylated IgA1 associated with pediatric IgA nephropathy","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS ONE"},{"key":"2025040309392680900_bib34","first-page":"364","article-title":"Risk factors for recurrent IgA nephropathy after renal transplantation: a meta-analysis","volume":"23","author":"Bai","year":"2023","journal-title":"Biomol Biomed"},{"key":"2025040309392680900_bib35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","article-title":"Treatment options in refractory autoimmune encephalitis","volume":"36","author":"Dinoto","year":"2022","journal-title":"CNS Drugs"},{"key":"2025040309392680900_bib36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.11.002","article-title":"Harnessing the potential of CD40 agonism in cancer therapy","volume":"75","author":"Zhou","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"2025040309392680900_bib37","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1158\/1078-0432.CCR-21-1047","article-title":"Neoadjuvant selicrelumab, an agonist CD40 antibody, induces changes in the tumor microenvironment in patients with resectable pancreatic cancer","volume":"27","author":"Byrne","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025040309392680900_bib38","doi-asserted-by":"publisher","first-page":"1210961","DOI":"10.3389\/fimmu.2023.1210961","article-title":"Proinflammatory role of monocytes in SARS-CoV-2 infection in chronic hemodialysis patients","volume":"14","author":"Bumbea","year":"2023","journal-title":"Front Immunol"},{"key":"2025040309392680900_bib39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1084\/jem.164.2.474","article-title":"Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody","volume":"164","author":"Clarkson","year":"1986","journal-title":"J Exp Med"},{"key":"2025040309392680900_bib40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2012-07-442541","article-title":"The high-affinity human IgG receptor Fc\u03b3RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy","volume":"121","author":"Mancardi","year":"2013","journal-title":"Blood"},{"key":"2025040309392680900_bib41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2025040309392680900_bib42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00281-018-0708-7","article-title":"IgA nephropathy: clearance kinetics of IgA-containing immune complexes","volume":"40","author":"Chen","year":"2018","journal-title":"Semin Immunopathol"},{"key":"2025040309392680900_bib43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.kint.2018.12.030","article-title":"CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis","volume":"95","author":"Helmke","year":"2019","journal-title":"Kidney Int"},{"key":"2025040309392680900_bib44","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/ki.2012.147","article-title":"Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy","volume":"82","author":"Cox","year":"2012","journal-title":"Kidney Int"},{"key":"2025040309392680900_bib45","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/ndt\/gfy169","article-title":"Plasma fractalkine levels are associated with renal inflammation and outcomes in immunoglobulin A nephropathy","volume":"34","author":"Luo","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2025040309392680900_bib46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1046\/j.1523-1755.1999.00604.x","article-title":"Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication","volume":"56","author":"Feng","year":"1999","journal-title":"Kidney Int"},{"key":"2025040309392680900_bib47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 Years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am Hum Genet"},{"key":"2025040309392680900_bib48","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","volume":"9","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"2025040309392680900_bib49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5301\/jn.5000218","article-title":"Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features","volume":"26","author":"Xin","year":"2013","journal-title":"J Nephrol"},{"key":"2025040309392680900_bib50","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.18632\/oncotarget.23232","article-title":"BAFF and APRIL expression as an autoimmune signature of membranous nephropathy","volume":"9","author":"Han","year":"2018","journal-title":"Oncotarget"},{"key":"2025040309392680900_bib51","doi-asserted-by":"publisher","first-page":"1213344","DOI":"10.3389\/fimmu.2023.1213344","article-title":"Activation and pro-inflammatory cytokine production by unswitched memory B cells during SARS-CoV-2 infection","volume":"14","author":"Castleman","year":"2023","journal-title":"Front Immunol"},{"key":"2025040309392680900_bib52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"2025040309392680900_bib53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","article-title":"Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond","volume":"141","author":"Karnell","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"2025040309392680900_bib54","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/CIRCRESAHA.116.308750","article-title":"Chronic kidney disease induces inflammatory CD40+ monocyte differentiation via homocysteine elevation and DNA hypomethylation","volume":"119","author":"Yang","year":"2016","journal-title":"Circ Res"},{"key":"2025040309392680900_bib55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1084\/jem.160.1.125","article-title":"Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice","volume":"160","author":"Rifai","year":"1984","journal-title":"J Exp Med"},{"key":"2025040309392680900_bib56","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1097\/TP.0000000000000813","article-title":"Advances on Non-CD4 + Foxp3+ T regulatory cells: CD8+, Type 1, and double negative T regulatory cells in organ transplantation","volume":"99","author":"Ligocki","year":"2015","journal-title":"Transplantation"},{"key":"2025040309392680900_bib57","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/00007890-199612270-00031","article-title":"Molecular executors of cell death\u2014differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and\/or chronic rejection of human renal allografts","volume":"62","author":"Sharma","year":"1996","journal-title":"Transplantation"},{"key":"2025040309392680900_bib58","doi-asserted-by":"publisher","first-page":"154206","DOI":"10.1016\/j.phymed.2022.154206","article-title":"Shenkang injection protects against renal fibrosis by reducing perforin expression through the STING\/TBK1\/IRF3 signaling pathways in natural killer cells","volume":"104","author":"Hao","year":"2022","journal-title":"Phytomedicine"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf057\/62115293\/sfaf057.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/3\/sfaf057\/62115293\/sfaf057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/3\/sfaf057\/62115293\/sfaf057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T10:31:13Z","timestamp":1743676273000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf057\/8038281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf057","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,24]]},"article-number":"sfaf057"}}